IBBvsITOT
iShares Biotechnology ETF against iShares Core S&P Total U.S. Stock Market ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | ITOT | |
|---|---|---|
| Expense ratio | 0.45% | 0.030% |
| Assets | $10.2B | $97.2B |
| Net flow, 1 month | +$86M | +$278M |
| Net flow, 1 year | +$1.5B | +$7.3B |
| Return, YTD | +28.4% | +13.1% |
| Return, 1 year | +57.3% | +20.7% |
| Avg daily volume | 1.4M | 1.5M |
| Holdings | 221 | 2523 |
| Listed | Feb 4, 2001 | Jan 19, 2004 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS